about
Using Chemical Reaction Kinetics to Predict Optimal Antibiotic Treatment Strategies.Deciphering the landscape of host barriers to Listeria monocytogenes infection.Population biological principles of drug-resistance evolution in infectious diseases.Estimating treatment prolongation for persistent infectionsQuantifying the impact of treatment history on plasmid-mediated resistance evolution in human gut microbiotaMulti-scale modeling of drug binding kinetics to predict drug efficacyTransposon-insertion sequencing screens unveil requirements for EHEC growth and intestinal colonizationReaction Kinetic Models of Antibiotic Heteroresistance
P50
Q36242447-AB61FBD5-4763-4318-BAD1-6C88E0DC4530Q36385494-07AAC5AE-8E46-423A-A4B4-82A6C0406B81Q37849394-312FA5B4-884B-41F2-851D-9C02812FC18AQ58792186-D6915546-FB4A-436C-BB52-C6DCC73BC5DFQ91010870-BE382977-B588-453B-B393-9A2E7FD235DFQ91455252-5CC56349-C93E-4FE4-8E38-2BB1BAA77CF9Q92564452-FB661D0B-EAFA-44C2-ACC1-3BB132FA7B71Q92822995-8CEF68E7-A626-4CE5-94DA-2D1AC4D6C29A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pia Abel zur Wiesch
@ast
Pia Abel zur Wiesch
@en
Pia Abel zur Wiesch
@es
Pia Abel zur Wiesch
@nl
type
label
Pia Abel zur Wiesch
@ast
Pia Abel zur Wiesch
@en
Pia Abel zur Wiesch
@es
Pia Abel zur Wiesch
@nl
prefLabel
Pia Abel zur Wiesch
@ast
Pia Abel zur Wiesch
@en
Pia Abel zur Wiesch
@es
Pia Abel zur Wiesch
@nl
P106
P31
P496
0000-0001-9420-9005